[Taktivin in the combined treatment of patients with ovarian cancer].
Griaznova
I M
IM
Makarov
O V
OV
Arion
V Ia
VIa
Kerbikova
V F
VF
Epeĭkina
T N
TN
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D010455:Peptides / Q000627:therapeutic use*; D011182:Postoperative Care; D011300:Preoperative Care; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin
Taktivin v kompleksnom lechenii bol'nykh rakom iaichnikov.